Hormone Replacement Therapy
Commons · Question 50771 · Tabled 7 May 2025 · Department of Health and Social Care · Official record
Answered 12 May 2025
Question
Asked by Freddie van Mierlo
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 March 2025 to Question 35541 on Hormone Replacement Therapy, what discussions he has had with the Medicines and Healthcare products Regulatory Agency on the adequacy of
Answer
Answered by Karin Smyth, 12 May 2025
The processes of the Medicines and Healthcare products Regulatory Agency (MHRA) are now performing within the expected timelines, and are meeting company commitments. Guidance has been updated on 3 April 2024 to aid the rapid approval of medicines, ensuri...